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Serine palmitoyltransferase (SPT) catalyzes the first committed
step in sphingolipid biosynthesis. In yeast, SPT is composed of a
heterodimer of 2 highly-related subunits, Lcb1p and Lcb2p, and a
third subunit, Tsc3p,which increases enzyme activitymarkedly and
is required for growth at elevated temperatures. Higher eukaryotic
orthologs of Lcb1p and Lcb2p have been identified, but SPT activity
is not highly correlatedwith coexpression of these subunits and no
ortholog of Tsc3p has been identified. Here, we report the discov-
ery of 2 proteins, ssSPTa and ssSPTb, which despite sharing no
homology with Tsc3p, each substantially enhance the activity of
mammalian SPT expressed in either yeast or mammalian cells and
therefore define an evolutionarily conserved family of low molec-
ular weight proteins that confer full enzyme activity. The 2 ssSPT
isoforms share a conserved hydrophobic central domain predicted
to reside in themembrane, and each interacts with both hLCB1 and
hLCB2 as assessed by positive split ubiquitin 2-hybrid analysis. The
presence of these small subunits, along with 2 hLCB2 isofoms,
suggests that there are 4 distinct human SPT isozymes. When each
SPT isozyme was expressed in either yeast or CHO LyB cells lacking
endogenous SPT activity, characterization of their in vitro enzy-
matic activities, and long-chain base (LCB) profiling revealed dif-
ferences in acyl-CoA preference that offer a potential explanation
for the observed diversity of LCB seen in mammalian cells.
long-chain bases  sphingolipids  HSAN1  ssSPT
Originally thought to be composed of a single subunit, geneticanalysis in yeast showed that eukaryotic serine palmitoyl-
transferase (SPT) is a heterodimer of 2 highly-related subunits,
Lcb1p and Lcb2p (1–3), associated with a third small subunit,
Tsc3p, that is required for maximal enzyme activity (4). Based
on the crystal structure of 8-amino-7-oxononanoate synthase (5),
and the identification of key catalytic residues in other -oxoam-
ine synthases, we proposed that SPT contains a single cytoplas-
mic catalytic site at the interface of a head-to-tail heterodimer
of Lcb1p and Lcb2p comprised of residues from both subunits
(6). This model is supported by the recently-reported crystal
structure of the homodimeric prokaryotic SPT (7). A second
Lcb2p-like subunit has been identified in both Arabidopsis and
mammalian cells (8, 9). In each case, the resulting LCB1–LCB2
heterodimers appear to catalyze the same reaction. Thus, their
roles are unclear. However, whereas in Arabidopsis the 2 iso-
forms are functionally redundant (8), mouse SPTLC2 knockouts
are embryonic lethal (10), suggesting that in mammalian cells the
2 LCB2 isoforms may have distinct functions.
We have shown that transfection of mammalian cells with the
human LCB1 ortholog (SPTLC1) and the LCB2-like isoform,
SPTLC2, produces only a modest increase in SPT activity,
despite high levels of protein expression (11). The same is true
for cotransfection of SPTLC1 and the other LCB2-like isoform,
SPTLC3 (9). This finding suggests that, like the situation in yeast,
an additional factor is required for full activity of mammalian
SPT. However, homology searches identified no higher eukary-
otic homologues of Tsc3p. A genetic screen was therefore
devised to search for additional mammalian subunits. We report
here the identification of 2 such subunits, named ssSPTa and
ssSPTb, for small subunits of SPT. The discovery of these
components of the committed and rate-limiting enzyme of
sphingolipid synthesis provides important mechanistic insights
into the biochemical basis of sphingolipid complexity.
Results
Identification of Stimulatory SPT Subunits. Because SPTLC1 is a
functional ortholog of yeast Lcb1p, and SPTLC2 and SPTLC3
are orthologous to yeast Lcb2p, we hereafter refer to SPTLC1
as hLCB1, SPTLC2 as hLCB2a, and SPTLC3 as hLCB2b. To
screen for additional subunits of mammalian SPT that confer
increased activity, we took advantage of the fact that hLCB1–
hLCB2 heterodimers support limited growth at 26 °C of a yeast
lcb1lcb2 mutant lacking endogenous SPT, but no growth at
37 °C (Fig. 1A Top). In contrast, the hLCB1–hLCB2b het-
erodimer barely supported growth even at 26 °C (Fig. 1B Top),
without the addition of phytosphingosine (PHS), which bypasses
the need for endogenous SPT. Because the hLCB1–hLCB2a
heterodimer more strongly complemented the PHS requirement
than the hLCB1–hLCB2b heterodimer, the yeast lcb1lcb2
mutant expressing this heterodimer was used to screen for
human Tsc3p orthologs by transforming a human cDNA expres-
sion library into this strain and selecting colonies that grew at
37 °C. From this screen, c14orf147 was identified. This gene
encodes a 71-aa protein with no homology to Tsc3p (Fig. 2A)
that allowed the hLCB1–hLCB2a heterodimer to support
growth of the yeast lcb1lcb2 mutant at 37 °C (Fig. 1A Middle;
ssSPTa). This protein also allowed the hLCB1–hLCB2b het-
erodimer to support growth of cells expressing this isoform at
both 26 °C and 37 °C (Fig. 1B Middle; ssSPTa) without the need
for PHS.
To determine whether ssSPTa would enhance the activity of
an hLCB1–hLCB2 heterodimer expressed in mammalian cells,
it was expressed alone or in combination with the other SPT
subunits in LyB cells that lack endogenous LCB1 and have
negligible SPT activity (12). The results of these experiments
show that c14orf147 (ssSPTa) was stably expressed in the
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presence or absence of any other SPT subunit and that, like
Tsc3p, is present in the microsomal fraction (Fig. 3A). More
significantly, coexpression of ssSPTa with either the hLCB1–
hLCB2a or hLCB1–hLCB2b heterodimer increased in vitro
activity in microsomes prepared from transfected cells by 10-
fold (Fig. 3B). These results suggest that endogenous levels of
ssSPTa limit SPT activity, thus providing an explanation for the
lack of a simple correlation between levels of hLCB1 and
hLCB2a/hLCB2b expression and SPT activity (11).
A second gene, identified as androgen-down-regulated in
mouse prostate (ADMP) (13), ADMP/c3orf57, encodes a 76-aa
protein with high homology (45% identity, 68% similarity) to
ssSPTa. Because ADMP is both structurally and functionally
related to ssSPTa, it is hereafter referred to as ssSPTb. Both
proteins contain 2 predicted membrane-spanning domains and
are highly conserved throughout evolution (Fig. 2 B and C).
However, there are distinct differences, particularly in their C
termini; the C-terminal ends of the ssSPTa family members are
highly conserved and different from the less highly-conserved
C-terminal ends of the ssSPTb family members. Despite these
differences, ssSPTb also enhances growth of lcb1 lcb2mutant
yeast cells expressing either hLCB1–hLCB2a or hLCB1–
hLCB2b heterodimers (Fig. 1 A and B Bottom; ssSPTb). Most
remarkably, although neither ssSPT isoform is homologous to
yeast Tsc3p or any other proteins in Saccharomyces cerevisiae,
both reverse the temperature sensitivity of a tsc3 mutant (Fig.
1C), demonstrating that although they are unrelated evolution-
Fig. 1. ssSPTa and ssSPTb enhance the growth of yeast cells expressing
human and yeast SPT heterodimers. Yeast lcb1lcb2mutant cells (TDY8055)
expressing hLCB1–hLCB2a (A), hLCB1–hLCB2b (B), or tsc3–2 mutant cells,
which lack Tsc3p but contain yeast Lcb1–Lcb2p (C), with empty vector (Top),
ssSPTa (Middle), or ssSPTb (Bottom) were transferred to yeast extract/
peptone/dextrose plates with or without PHS and incubated at 26 °C or 37 °C.
Fig. 2. ssSPTa and ssSPTb define a new gene family. (A) The ssSPT proteins are homologous to each other but share no homology with yeast Tsc3p. (B and C)
The ssSPTa (B) and ssSPTb (C) subfamilies contain a highly-conserved central domain that extends from just after the first predictedmembrane spanning domain
(TMD1) through TMD2.
Fig. 3. ssSPTa stimulates SPT activity in mammalian cells. CHO-LyB cells were
transfected with plasmids expressing hLCB1, hLCB2a, hLCB2b, or HA-tagged
ssSPTa as indicated. Microsomal protein was prepared from the transfected
cells. (A) Expression of each protein was analyzed by immunoblotting using
antipeptide antibodies for detecting hLCB1, hLCB2a, and hLCB2b and anti-HA
antibodies for detecting HA-ssSPTa. (B) SPT activity was determined as de-
scribed in Materials and Methods.
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arily to Tsc3p, they serve a common function and potentially
recognize a common structural feature in the yeast and mam-
malian heterodimers.
Analysis of SPT Subunit Interactions. The results described above
suggest that both ssSPTa and ssSPTb interact with canonical
SPT heterodimers. This idea was confirmed by showing that
hLCB1–HA-NubG and NubG-HA-tagged ssSPTa/ssSPTb co-
purified with hLCB2b-TAP (Fig. 4A) when adsorbed to IgG
Sepharose. These results do not address the stoichiometry of the
complex because the HA epitopes in hLCB1–HA-NubG and
NubG-HA–ssSPTa/b may not be equally accessible and the 2
proteins may transfer with different efficiencies. To explore
subunit interactions further, a split ubiquitin 2-hybrid system was
used (14). As expected, the hLCB1–C-terminal domain of
ubiquitin (Cub) showed a positive interaction with either
hLCB2a–NubG or hLCB2b–NubG (Fig. 4B). hLCB1–Cub also
showed a positive interaction with NubG–ssSPTa and NubG–
ssSPTb. Thus, these proteins interact directly with hLCB1, even
in the absence of an hLCB2 subunit. Neither NubG–ssSPTa nor
NubG–ssSPTb appeared to interact directly with hLCB2a–Cub
or hLCB2b–Cub unless hLCB1 was present. However, these
results need to be interpreted with care, because hLCB2a cannot
be stably expressed in the absence of hLCB1 (Fig. 5A) and
hLCB2b–GFP showed aberrant localization in the absence of
hLCB1 in both yeast and mammalian cells. Nonetheless, it is
clear that when coexpressed with hLCB1, the Cub domains of
the hLCB2–Cub proteins interact with the NubG domains of the
NubG–ssSPT proteins (Fig. 4B). Combined with the interaction
between hLCB1–Cub and either NubG–ssSPT isoform, these
data strongly suggest that the N termini of the ssSPTs are in close
proximity to the C-terminal ends of both hLCB1 and the hLCB2s
when the latter are present as heterodimers.
The 2-hybrid analysis also allowed us to investigate the re-
ported presence of higher-order complexes containing both
hLCB2 isoforms (15). Examination of cells expressing hLCB1,
hLCB2a–Cub, and hLCB2b–NubG or hLCB1, hLCB2b–Cub,
and hLCB2a–NubG failed to provide any evidence for an
interaction between the C-terminal ends of hLCB2a and
hLCB2b. Nor, in the presence of hLCB1, was there any inter-
action of hLCB2a–Cub with hLCB2a–NubG or hLCB2b–Cub
with hLCB2b–NubG (Fig. 4B). Thus, if higher-order complexes
exist, their organization is such that the C-terminal ends of the
2 hLCB2 isoforms are not topologically positioned to report a
2-hybrid interaction.
Both ssSPT Orthologs Activate the Human SPT Heterodimeric Isoforms
in Yeast. Transient transfection of LyB cells with ssSPTa stimu-
lated SPT activity 10-fold (Fig. 3). However, in these experi-
ments only a fraction of the cells express all 3 proteins, and
endogenous levels of the ssSPT subunits are unknown. The
ability to reconstitute mammalian SPT in yeast afforded the
Fig. 4. Interactions between human SPT subunits. (A) Solubilized yeast
microsomes prepared from cells expressing hLCB2b–TAP, hLCB1-HA–NubG
and NubG-HA–ssSPTa (lanes 5 and 6) or NubG-HA–ssSPTb (lanes 7 and 8) or
cells expressing only NubG-HA–ssSPTa (lanes 1 and 2) or NubG-HA–ssSPTb
(lanes 3 and 4) were incubatedwith IgG-conjugated Sepharose, and unbound
(U) and bound (B) proteins were detected by immunoblotting. The smaller of
the 2 hLCB1-HA–NubG bands seen in the unbound lanes appears to be a
proteolytic fragment not present in the holoenzyme. (B) Split-ubiquitin 2-
hybrid interactionsbetweenhLCB1and theother SPT subunitswere identified
by using hLCB1–Cub and C-terminally Nub-tagged hLCB2 isoforms or N-
terminally Nub-tagged ssSPT isoforms. Interactions between hLCB2 isoforms
and ssSPT isoforms were determined by using N-terminally Cub-tagged
hLCB2s and N-terminally Nub-tagged ssSPTs in the presence or absence of
untagged hLCB1. Potential interactions between hLCB2 isoforms were inves-
tigated by using C-terminally Nub-tagged and N-terminally Cub-tagged pro-
teins. Positive interactions were detected by growth on medium lacking
histidine and containing 50 mM aminotriazole.
Fig. 5. Reconstitution of human SPT activity in yeast. Human SPT subunits
were expressed in lcb1lcb2 double mutant yeast cells in various combina-
tions as indicated. Protein expression was verified by immunoblotting as in
Fig. 3 (A) and microsomal SPT activity assayed with [3H]serine and palmitoyl-
CoA (B).
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opportunity to examine each potential multimeric SPT complex
in the absence of any endogenous SPT subunits or activity. All
5 human SPT subunits could be stably expressed in yeast,
although as has been reported (11, 16), hLCB2a expression
required coexpression of hLCB1 (Fig. 5A). Consistent with the
results in Fig. 1, both the hLCB1–hLCB2a and the hLCB1–
hLCB2b heterodimers had extremely low basal SPT activity (Fig.
5B). In contrast, when expressed with the ssSPTs, all 4 isozymes
had dramatically higher SPT activity, with the hLCB1–hLCB2a–
ssSPTa combination being the most active. Although the basal
activity of the hLCB1–hLCB2b heterodimer was lower, ssSPTa
stimulated it to the same extent as it did the hLCB1–hLCB2a
heterodimer. These experiments also demonstrate that ssSPTb
increases the activity of both heterodimers, albeit to a lesser
extent.
Four SPT Isozymes Have Distinct Acyl-CoA Preferences. Surprisingly,
the LCB profiles of yeast cells expressing each of the human SPT
isozymes differed, most strikingly in that cells expressing ssSPTb
accumulate significant levels of C20-PHS and C20-dihydrosph-
inganine (DHS) (Fig. 6A, solid line), not seen in cells expressing
ssSPTa (Fig. 6A, dotted line). The profiles shown are for the
hLCB1–hLCB2a heterodimer, but a similar result was seen for
the hLCB1–hLCB2b heterodimer. This observation, along with
the presence of structurally diverse LCBs predicted to be derived
from acyl-CoAs other than palmitoyl-CoA in mammalian cells
(17), and our previous discovery that a viral fusion SPT prefers
myristoyl-CoA as substrate (18), suggested that the different
isozymes have different acyl-CoA preferences. This hypothesis
was confirmed by assaying each of the SPT isozymes with a panel
of acyl-CoA substrates. The most active and selective isozyme
was hLCB1–hLCB2a–ssSPTa showing a strong preference for
C16–CoA (Fig. 6B). In contrast, the hLCB1–hLCB2b–ssSPTa
isozyme used C14–CoA as well, if not slightly better than,
C16–CoA (Fig. 6B). Remarkably, isozymes containing the
ssSPTb subunit preferred longer acyl-CoAs. The hLCB1–
hLCB2a–ssSPTb enzyme showed a clear preference for C18–
CoA, whereas the hLCB1–hLCB2b–ssSPTb multimer displayed
an ability to use a broader range of acyl-CoAs, without apparent
preference (Fig. 6B). Despite their different acyl-CoA prefer-
ences, the KM for serine for each of the 4 isozymes was1–2 mM
when assayed with the preferred acyl-CoA acceptor. These
results suggest that a heretofore-unappreciated diversity of SPT
enzymes is responsible for the synthesis of a complex family of
LCBs with potentially unique biological properties.
The ability of the ssSPT subunits to modulate the chain
lengths of LCBs in mammalian cells was investigated by com-
paring the amounts of C20–LCBs in LyB cells expressing the 4
combinations of SPT subunits. The results showed that, as
observed in yeast (Fig. 6A), coexpression of ssSPTa with either
the hLCB1–LCB2a or hLCB1–LCB2b heterodimer did not
produce significant amounts of either C20–DHS or C20–
sphingosine (SPH). In contrast, coexpression of either het-
erodimer with ssSPTb resulted in a substantial increase in the
levels of both C20–DHS and C20–SPH (Fig. 7A). This difference
was also seen in in vitro assays using microsomes prepared from
LyB cells transfected with hLCB1, hLCB2a, and either ssSPT
isoform. Microsomes prepared from cells transfected with
ssSPTa were highly selective for C16–CoA; little activity was
observed with shorter or longer acyl-CoA substrates. However,
microsomes prepared from cells transfected with ssSPTb had
substantial activity when C18–CoA was presented as the sub-
strate (Fig. 7B). In these experiments it is important to note that
Fig. 6. Human SPT isozymes synthesize different LCBs. (A) LCBs were ex-
tracted from yeast expressing the hLCB1–hLCB2a heterodimer alone (Inset) or
coexpressed with ssSPTa (dotted line) or ssSPTb (solid line) and analyzed by
HPLC. Note that cells expressing only the heterodimer (Inset) accumulate
significantly less LCBs than those coexpressing either ssSPTa or ssSPTb. (B) SPT
activity was measured in microsomes prepared from yeast expressing each of
the 4 isozymes using [3H]serine andacyl-CoAs of the indicated (C12–C20) chain
lengths.
Fig. 7. Expression of ssSPTb-containing isozymes in CHO LyB cells increases
C20–LCBs. (A) LCBs were extracted from LyB cells expressing each of the 4
human SPT isozymes and levels of C20–SPH and C20–DHS were quantified. (B
andC)Microsomeswereprepared fromLyB cells expressinghLCB1andhLCB2a
with either ssSPTa (B) or ssSPTb (C), and SPT activity was measured by using
[3H]serine and acyl-CoAs of the indicated (C12–C22) chain lengths.
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SPT multimers containing endogenous ssSPTs contribute to
overall activities measured. Thus, although the results with
ssSPTb appear less dramatic than those seen in yeast (Fig. 6B),
they almost certainly underestimate the selectivity conferred by
the ssSPTb isoform. In any case, they clearly confirm that the
ssSPT subunits alter the acyl-CoA selectivity of SPT in mam-
malian cells.
Discussion
Although coexpression of hLCB1 with either hLCB2 subunit in
mammalian cells increases SPT activity, the increased activity
does not correlate well with the levels of subunit expression (11).
In addition, we have recently coexpressed the LCB1 and LCB2
subunits from a variety of higher eukaryotes in lcb1 lcb2 yeast
and found none conferred activity comparable to that measured
in the organisms of origin (8, 19). Thus, it seemed reasonable to
expect that an additional component is required to achieve
optimal SPT activity. Indeed, we discovered such a component,
Tsc3p, in yeast (4). However, homology searches failed to
identify candidates from higher eukaryotes, necessitating the use
of a functional screening assay for their identification. This
screen allowed us to identify 2 short membrane proteins that, by
a variety of criteria, appear to be the functional orthologs of yeast
Tsc3p. Although SPT activity is apparently not highly regulated,
a variety of stimuli have been reported to modulate activity a few
fold without altering the levels of the LCB1 or LCB2 mRNAs or
proteins (20–22). While it is possible that the ssSPTs contribute
to regulation of enzyme activity, given the observation that all 3
proteins copurify it seems more likely that they are integral
subunits of the SPT holoenzymes, a conclusion entirely consis-
tent with the extremely small increase in SPT activity observed
when the hLCB1 and hLCB2 subunits are overexpressed by
themselves. Nonetheless, because the 2 subunits confer different
acyl-CoA selectivities, they do have the potential to regulate the
species of LCBs generated. Interestingly, Cowart and Hannun
(23) reported a Tsc3p-dependent increase in C20–LCBs in yeast
after transient heat shock.
The split-ubiquitin assay used N-terminally NubG-HA-tagged
ssSPT isoforms, allowing us to conclude that their N termini are
cytoplasmic. The location of the C terminus has not been
experimentally determined. Because the 28-aa central domain is
the most highly-conserved region of the ssSPTs, it seems likely
that it is this domain that interacts with the hLCB1–hLCB2
heterodimers. Hydropathy analysis predicts that most of this
domain resides in the membrane, suggesting that the interaction
of the ssSPT isoforms with hLCB1 and hLCB2 is in the
membrane. The N- and C-terminal ends of ssSPTa and ssSPTb
are divergent from each other, but conserved within the ssSPTa
and ssSPTb subfamilies. Protease sensitivity (16, 24) and topo-
logical analysis (11) place the catalytic domain of SPT in the
cytoplasm. Thus, it is tempting to speculate that the differences
in acyl-CoA preferences conferred by the ssSPT proteins reflect
an interaction between their N- and/or C-terminal regions with
the active site of the heterodimer. However, even within the
central domain there are clear differences between the ssSPTa
and ssSPTb families that could also contribute to acyl-CoA
selectivity. In addition, we cannot exclude the possibility that the
SPT holoenzyme contains 1 ssSPT subunit, a configuration
that would increase the potential complexity of the acyl-CoA
preferences.
Although no function has previously been assigned to ssSPTa,
‘‘gene atlas’’ (25) expression data indicate that it is ubiquitously
expressed, albeit at different levels, with highest expression seen
in the adrenal gland, lung, salivary gland, prostate, and placenta.
In contrast, a mouse ortholog of ssSPTb was originally described
as an ADMP in mouse prostate (13). In hypogonadal mice
expression was restricted to the prostate, whereas in normal mice
there was little, if any, expression in the prostate but robust
expression in kidney and brain. These results suggest that
androgens could regulate the LCB base composition in androgen
target tissues. Indeed, it has been observed in Drosophila that
sperm production is reduced in mutants lacking the LCB-
desaturase required for sphingosine synthesis (26). Moreover,
mice overexpressing the hereditary sensory autonomic neurop-
athy (HSAN) mutant LCB1 subunit showed clear evidence of
aspermatogenesis (27).
There are numerous reports of novel LCBs (17), including
some with unusual chain lengths that appear to be derived from
substrates other than palmitoyl-CoA. The data presented here
provide direct evidence for the presence of SPT isozymes with
distinct acyl-CoA preferences. We have described a virally-
encoded single-chain fusion SPT with a preference for myristoyl-
CoA (18). In contrast, mammalian SPT isozymes containing
ssSPTb prefer longer acyl-CoAs. It is known that different
ceramide synthases have preferences for different fatty acids. It
will therefore be interesting to determine whether they also
exhibit a preference for LCBs of different lengths.
HSAN1 is the result of dominant mutations in hLCB1 (28, 29).
It has been presumed that these mutations lead to a 50%
decrease in SPT activity in all tissues. However, the fact that
nonsense or frameshift mutations have not been identified in
HSAN patients and that mutation of only 2 residues has been
conclusively linked to the disease suggests that a simple haplo-
insufficiency cannot explain the phenotype. The discovery that
ssSPT subunits can alter substrate specificity, combined with the
location of the mutations near the active site of the enzyme,
suggests alternative explanations that will need to be experi-
mentally tested.
Materials and Methods
Yeast Strains. The yeast strain TDY6049 (Mata lcb1KAN lcb2KAN leu2 ura3
his3 met 15 lys2) was constructed by crossing haploid lcb1KAN and lcb2KAN
mutants derived from heterozygous knockout strains (OpenBiosystems) fol-
lowedby tetrad dissection. The TRP1genewas then replacedwithHIS3 to create
TDY8055 in which hLCB1–hLCB2a and hLCB1–hLCB2b heterodimers were ex-
pressed for the functional complementation screens. Aura3mutant of strain L40
(Mata, trp1–901 leu2–3,112 his3200 lys2–801 ade2 ura3 LYS2::lexA-HIS3
ura3::lexA-lacZ) (30) was selected on 5-fluoroorotic acid for the split ubiquitin
yeast 2-hybrid study. The tsc3–2mutant has been described (4).
Complementation Cloning of ssSPTa. A NubG-HA-X human library prepared
from whole brain was purchased from Dualsystems Biotech and transformed
into TDY8055 expressing hLCB1 and hLCB2a. From5 105 transformants, 2
colonies that grew well at 37 °C were selected for further analysis. Plasmids
were purified by passage through Escherichia coli and their ability to com-
plement confirmed upon reintroduction into TDY8055/hLCB1-hLCB2a. The
plasmids (pPR3N-NubG-HA-ssSPTa) recovered from the 2 yeast transformants
were identical.
Mammalian Expression of SPT Subunits. LyB CHO cells (12) were grown and
transfected as described (11). pCMV6-based plasmids expressing hLCB1 or
hLCB2awere purchased fromOriGene. hLCB2b cDNAwas prepared by RT-PCR
using HEK mRNA by standard methods and inserted into pcDNA. The NubG-
HA–ssSPTa insert frompPR3N–NubG-HA–ssSPTawas excised by digestionwith
XhoI and SpeI and ligated into pcDNA to generate pcDNA–NubG-HA–ssSPTa.
The pcDNA–NubG-HA–ssSPTb plasmid was constructed by the same strategy.
Yeast Expression of SPT Subunits. A yeast expression vector, pGH316, was
constructed by inserting a fragment of the yeast LCB2 gene including 680 bp
of upstream and 345 bp of downstream flanking sequence into pRS316
followed by replacement of the entire coding sequence with an NheI site. For
expression under control of the yeast LCB2 promoter, PCR fragments contain-
ing hLCB1, hLCB2a, or hLCB2b were inserted into the NheI site of pGH316.
Expression plasmids with LEU2 substituted for the URA3 marker were also
constructed to allow for pairwise expression of the human SPT subunits. To
generate a plasmid for expression of ssSPTb in yeast, an SfiI-ended PCR
fragment containing the open-reading frame of ssSPTb was substituted for
the ssSPTa open-reading frame in pPR3N–NubG-HA–ssSPTa.
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Measurement of SPT Activity.Microsomal proteins were prepared from LyB or
yeast cells expressing the human SPT subunits, and hLCB1 and hLCB2a were
detected by immunoblotting as described (11). For detection of hLCB2b,
antibodies against C-terminal peptides of hLCB2bwere generated (Covance).
The NubG–ssSPTs, containing an HA tag after the Nub domain, were detected
by using anti-HA antibodies. For determination of SPT activity, a reaction
containing 50mMHepes (pH 8.1), 50 Mpyridoxyl phosphate, 2 mMNADPH,
2 mM NADH, 10 mM L- [G-3H]serine (10 Ci/mL), 75 or 100 M acyl-CoA, and
0.2–0.4 mg of microsomal membranes was incubated at 37 °C for 10 min. The
reaction was stopped and the products were extracted and quantified as
described (4).
Affinity Purification of SPT. hLCB2b–TAP was constructed by inserting an
SpeI-ended TAP cassette into an NheI site introduced by Quikchange mu-
tagenesis before the stop codon of hLCB2b. Microsomes prepared from yeast
coexpressing hLCB1-HA–NubG, hLCB2b–TAP, NubG-HA–ssSPTa, or NubG-HA–
ssSPTb were solubilized with 0.1% sucrose monolaurate and incubated with
IgG-conjugated Sepharose beads for 14 h at 4 °C. After washing 4 times with
50 mM TrisHCl, pH 7.5, 1 mM EGTA, the beads were boiled in SDS sample
buffer and proteins were resolved by SDS/PAGE and visualized by immuno-
blottingwith anti-HA antibodies that recognize the NubG-HA subunits, and a
secondary antibody that recognizes the primary antibody and the protein A
epitope in hLCB2–TAP.
LCB Extraction and Analysis. LCBs were extracted, derivatized for detection,
and resolved by HPLC according to published procedures (31).
Split-Ubiquitin 2-Hybrid Constructs. For C-terminal Cub tagging of SPT sub-
units, a Cub-LexA-VP16 cassette was inserted in-frame before the stop codon
of hLCB1, hLCB2a, or hLCB2b. For C-terminal Nub tagging of SPT subunits, a
NubG-HA cassettewas inserted before the stop codon of hLCB2a and hLCB2b.
The NubG-HA—ssSPT-expressing plasmids are described above. Potentially
interacting Nub and Cub-tagged subunits were coexpressed in the ura3
derivative of L40 described above and interactions were identified by the
ability of the transformed cells to grow in the absence of histidine in the
presence of 50 mM 3-aminotriazole.
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MICROBIOLOGY
Correction for ‘‘Fixation and fate of C and N in the cyanobac-
terium Trichodesmium using nanometer-scale secondary ion
mass spectrometry,’’ by Juliette A. Finzi-Hart, Jennifer Pett-
Ridge, Peter K. Weber, Radu Popa, Stewart J. Fallon, Troy
Gunderson, Ian D. Hutcheon, Kenneth H. Nealson, and Douglas
G. Capone, which appeared in issue 15, April 14, 2009, of Proc
Natl Acad Sci USA (106:6345–6350; first published March 30,
2009; 10.1073/pnas.0810547106).
The authors note that due to a printer’s error, on page
6346, the following text was not included in the legend for
Fig. 1A: ‘‘Photo credit: R. Foster (University of California,
Santa Cruz, CA).’’ The figure and its corrected legend appear
below.
NEUROSCIENCE
Correction for ‘‘Evidence on the emergence of the brain’s
default network from 2-week-old to 2-year-old healthy pediatric
subjects,’’ byWei Gao, Hongtu Zhu, Kelly S. Giovanello, J. Keith
Smith, Dinggang Shen, John H. Gilmore, and Weili Lin, which
appeared in issue 16, April 21, 2009, of Proc Natl Acad Sci USA
(106:6790–6795; first published April 7, 2009; 10.1073/
pnas.0811221106).
The authors note that on page 6790, right column, the eighth
line of the first full paragraph, ‘‘Uidden et al. (13) investigated
the 2 hubs of the default network and found that the interaction
patterns with other networks are significantly different for these
2 hubs, suggesting functional differentiation within the default
network,’’ should instead read ‘‘Uddin et al. (13) investigated the
2 hubs of the default network and found that the interaction
patterns with other networks are significantly different for these
2 hubs, suggesting functional differentiation within the default
network.’’
www.pnas.org/cgi/doi/10.1073/pnas.0905295106
BIOCHEMISTRY
Correction for ‘‘Identification of small subunits of mammalian
serine palmitoyltransferase that confer distinct acyl-CoA sub-
strate specificities,’’ by Gongshe Han, Sita D. Gupta, Kenneth
Gable, Somashekarappa Niranjanakumari, Prasun Moitra, Flo-
rian Eichler, Robert H. Brown, Jr., Jeffrey M. Harmon, and
Teresa M. Dunn, which appeared in issue 20, May 19, 2009, of
Proc Natl Acad Sci USA (106:8186–8191; first published May 5,
2009; 10.1073/pnas.0811269106).
The authors note that the reference numbers throughout the
article appeared incorrectly and that four references were inad-
vertently omitted from the reference list. The online version has
been corrected.
www.pnas.org/cgi/doi/10.1073/pnas.0905301106
A B C
Fig. 1. Images of Trichodesmiumfilaments at 3 levels ofmagnification. (A) Image of Trichodesmium tuft (T) and puff (P) taken under green excitation (510–560
nm). Photo credit: R. Foster (University of California, SantaCruz, CA). (B) Imageof single Trichodesmium trichomebyusing lightmicroscopy at 20magnification.
(C) TEM image of individual Trichodesmium cell, demonstrating a cyanophycin granule (C), gas vesicles (G), and thylacoid membranes (Th).
www.pnas.org/cgi/doi/10.1073/pnas.0904281106
www.pnas.org PNAS  June 16, 2009  vol. 106  no. 24  9931–9932
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